Results
Results Summary
In summary, within the framework of the 3D-ORco project, the development of research tools and protocols for the expression, solubilization with detergents and nanodiscs,, as well as that of purification of recombinant AgamORco using chromatographic techniques, was achieved, and can be applied as-is in large scale. Reliable models of the AgamORco and AgamORco•ligand complexes were also created, and the Receptor-ligand interactions that are perceived as critical for odorant recognition by the receptor, were proposed. Conclusions were drawn about the relationship between ligand structure and inhibition mechanism (orthosteric or allosteric in relation to the agonist binding site). Furthermore, functional studies revealed new potent natural antagonists of ORco, which were confirmed as repellents by in vivo bioassays. Moreover, these studies guided the creation of a virtual platform for the selection of orthosteric antagonists. To the best of our knowledge, our study is the first one that combines a pharmacophore with a SVM model for identification of AgamORco antagonists and specifically orthosteric ones that are advantageous for future site-specific ORco structure-based screening as compared to blind-docking trials. To this end, our pipeline can constitute the first ligand-based step for screening large chemical libraries and proposing candidates for subsequent site-specific molecular docking and MD simulations against AgamORco homology models. Such a structure-based approach, utilizing the 3D model of AgamORco produced in the framework of 3D-ORco, is currently underway for seeking both novel active compounds and gaining structural insights on ligand recognition mechanism by the receptor.
In conclusion, the goals of the 3D-ORco, namely the understanding of the rules governing the recognition of odor molecules by the 7-transmembrane olfactory co-receptor ORco and, furthermore, the discovery of multiple new effective disruptors of host-seeking behavior, were fully achieved.
Publications
Georgia Kythreoti, Trias Thireou, Christos Karoussiotis, Zafiroula Georgoussi, Panagiota GV Liggri, Dimitrios P Papachristos, Antonios Michaelakis, Vassileios Karras, Spyros E Zographos*, Stefan Schulz, Kostas Iatrou* (2024). Natural volatiles preventing mosquito biting: an integrated screening platform for accelerated discovery of ORco antagonists. J. Biol. Chem. 300, 107939 DOI: 10.1016/j.jbc.2024.107939 | Read Full Article
Georgia Kythreoti, Trias Thireou, Christos Karoussiotis, Zafiroula Georgoussi, Panagiota GV Liggri, Dimitrios P Papachristos, Antonios Michaelakis, Vassileios Karras, Spyros E Zographos*, Stefan Schulz, Kostas Iatrou* (2024). Natural volatiles causing inhibition of mosquito biting behaviors: development of a virtual screening platform predicting antagonists of ORco function for accelerated discovery. bioRxiv 2024.06.24.600390. DOI: 10.1101/2024.06.24.600390 | Read Full Article
Iatrou, K., Kythreoti, G., Thireou, T., Karoussiotis, C., Georgoussi, Z., Zographos, S.E., Liggri, P.G.V., Michaelakis, A., Schulz, S. (2022) Novel Anosmia-Inducing Compounds for Environmentally Friendly Mosquito Vector Control: Structural Determinants of ORco Ligands Antagonizing Odorant Receptor Function. Experimental Biology Annual Meeting (EB 2022), 2-5 April 2022, Philadelphia, PA, USA. Category: Pharmacology, Session: 537 Drug Discovery and Development - General I. (Poster 537.15). FASEB J. (2022) 36, Suppl. 1. DOI: 10.1096/fasebj.2022.36.S1.R4433 | Read Abstract
Kostas Iatrou, Trias Thireou, Georgia Kythreoti, Panagiota Liggri, Antonios Michaelakis, Dimitrios Papachristos, Katerina Tsitsanou, Spyros Zographos, and Stefan Schulz (2024). Natural anosmia-inducing compounds for control of mosquito biting behaviors: Machine learning-assisted determination of structural determinants for ORco ligands antagonizing odorant receptor function. Annual meeting of the American Society for Biochemistry and Molecular Biology (Discover BMB 2024), March 23–26, San Antonio, USA. Topic Category: Drug Discovery. Abstract ID: 1161. J Biol. Chem. (2024) 300, Issue 3, (Suppl. 9), S168. DOI: 10.1016/j.jbc.2024.106064 | Read Abstract
Conference Presentations
T. Thireou, G. Kythreoti, P.G.V Liggri, A. Michaelakis, D.P. Papachristos, K.E. Tsitsanou, S.E. Zographos, K. Iatrou (2023). Structural determinants of ORco ligands antagonizing odorant receptor function for mosquito vector control. - XII European Congress Of Entomology (ECE2023), November 16-20, Cultural Conference Center of Heraklion Crete, Greece. Session 9: Medical and Veterinary Entomology. Theme 3: Innovative Vector Control Strategies: Adapting to the Future. (Poster P304) | Read Abstract
T. Thireou, G. Kythreoti, K.E. Tsitsanou, P.G.V Liggri, S.E. Zographos, K. Iatrou (2023). Generating a two-step in silico screening protocol to predict ORco ligands antagonizing mosquito odorant receptor function. Proceedings of the 11th International Conference of the Hellenic Crystallographic Association (HeCrA), p. 76. Municipal Art Gallery - G.I. Katsigras Museum of Larissa, Greece, 20-22 October 2023. Session 2 - Structural Biology. | Read Abstract
E. Christodoulou, E.C.V. Stamati, Κ.Ε. Tsitsanou, G. Kontopidis, S.E. Zographos (2023). The structure of a novel Odorant Binding Protein of Anopheles gambiae in complex with ORco effectors. Proceedings of the 11th International Conference of the Hellenic Crystallographic Association (HeCrA), p. 63. Municipal Art Gallery - G.I. Katsigras Museum of Larissa, Greece, 20-22 October 2023. Session 2 - Structural Biology. | Read Abstract
“Nikos Oikonomakos” award for best poster presentation.
Trias Thireou, Georgia Kythreoti, Panagiota G.V. Liggri, Antonios Michaelakis, Dimitrios P. Papachristos, Katerina E. Tsitsanou, Spyros E. Zographos, Kostas Iatrou (2023). Combining a pharmacophore and an artificial intelligence approach to predict ORco ligands antagonizing mosquito odorant receptor function. 30th Meeting of the Hellenic Society for Neuroscience (HSfN), 24-26 November, National Center for Scientific Research “Demikritos”, Athens, Greece. (Poster PP054) | Read Abstract
Production of Recombinant AgamORco in
Insect (Hi5) and Mammalian Cells (Expi293)
Western blot analysis of AgamORco produced from Hi5 insect cells. Membrane protein was solubilized by 0.25% LMNG detergent and 0.05% CHS additive or SMALP200-nanodiscs and purified by antibody (left) or metal (right) affinity chromatography. The total yield was estimated to be 0.2-0.4 μg/mL of culture of transiently transfected cells.
Detergents screening by Fluorescence-Detection Size-Exclusion Chromatography (F-SEC). The peak eluting in the presence of 0.01% LMNG detergent (green line) at ~8.25 mL corresponds to a protein of molecular weight between 158 kDa and 670 kDa. Based on elution volumes of reference proteins (right), the peak corresponds to the AgamORco tetramer (10xHis-3C-ORco-3C-GFP-8xHis) with an expected MW of ~330 kDa
AgamORco 3D Structures
The three-dimensional model of AgamORco produced by iBio-GATS platform (Chidambara Thanu V, et al., 2024, Int J Mol Sci. 25, 3055. DOI: 10.3390/ijms25053055) using the Apocrypta bakeri fig wasp Orco; AbORco (PDB ID 6C70) as template.
Left: Cartoon representation of AgamORco with a blue to red color spectrum from the amino- to carboxy-terminus. Right: Superimposition of AgamORco (blue) with the Cryo-EM structure of AbORco (green). The RMSD calculated on all heavy atoms of the molecule was 0.273 Å.
Molecular Docking and Dynamics Simulation revealed the bindinng mode of the agonist ORcoRAM1 into rhe AgamORco binding site.
Molecular Docking and Dynamics of Orthsteric ORco Antagonists. In viro confirmed Orthosteric Antagonosts (Kythreoti, G., et al 2024, bioRxiv 2024.06.24.600390. DOI: 10.1101/2024.06.24.600390) compete with ORcoRAM1 agonist for the same binding site.